Tag:
Drug Efficacy
Latest Headlines
Latest Headlines
Developers find that Phase II hurdle is getting harder to clear
Phase II has long represented the key crossroads for a biotech company. Getting a promising outcome is a good way to earn a lucrative partnering deal, possibly even a buyout. But a new analysis shows
